Safety Evaluation of Biotechnologically-derived Pharmaceuticals

Safety Evaluation of Biotechnologically-derived Pharmaceuticals
Author :
Publisher : Springer Science & Business Media
Total Pages : 208
Release :
ISBN-10 : 9789401148764
ISBN-13 : 9401148767
Rating : 4/5 (767 Downloads)

Book Synopsis Safety Evaluation of Biotechnologically-derived Pharmaceuticals by : Susan A. Griffiths

Download or read book Safety Evaluation of Biotechnologically-derived Pharmaceuticals written by Susan A. Griffiths and published by Springer Science & Business Media. This book was released on 2012-12-06 with total page 208 pages. Available in PDF, EPUB and Kindle. Book excerpt: Considerable investment has been made by both pharmaceutical and biotechnology companies in pharmaceutical products of biotechnology. However, because relatively few of these products have been marketed, lack of relevant experience means that uncertainty still surrounds the most appropriate strategy for their safety evaluation. The 13th CMR International Workshop, held in February 1997, provided the opportunity for regulatory authority and industry experts from Europe, Japan and the USA to share their experiences of designing safety evaluation programmes for specific product classes: colony stimulating factors, growth factors, hormones, interferons, interleukins, monoclonal antibodies for therapeutic use, and gene therapy products. Participants worked together to recommend those studies that should be considered for such safety evaluation, and those that may be unnecessary. These recommendations subsequently made a valuable contribution to the ICH guideline `Safety Studies for Biotechnological Products', which was finalised at ICH 4 in Brussels in July 1997. The Workshop proceedings not only describe the recommendations but also provide the reader with an appreciation of the science behind safety evaluation strategies used by experts, the influence of different regulatory systems on these strategies, and the type of data required by both toxicologists and clinicians before they have sufficient confidence to administer pharmaceutical products of biotechnology to humans.


Safety Evaluation of Biotechnologically-derived Pharmaceuticals Related Books

Safety Evaluation of Biotechnologically-derived Pharmaceuticals
Language: en
Pages: 208
Authors: Susan A. Griffiths
Categories: Medical
Type: BOOK - Published: 2012-12-06 - Publisher: Springer Science & Business Media

DOWNLOAD EBOOK

Considerable investment has been made by both pharmaceutical and biotechnology companies in pharmaceutical products of biotechnology. However, because relativel
Guidance for industry
Language: en
Pages: 11
Authors:
Categories: Biopharmaceutics
Type: BOOK - Published: 1997 - Publisher:

DOWNLOAD EBOOK

Addendum to ICH S6
Language: en
Pages: 14
Authors:
Categories: Drugs
Type: BOOK - Published: 2009 - Publisher:

DOWNLOAD EBOOK

Preclinical Safety Evaluation of Biopharmaceuticals
Language: en
Pages: 1012
Authors: Joy A. Cavagnaro
Categories: Medical
Type: BOOK - Published: 2013-03-07 - Publisher: John Wiley & Sons

DOWNLOAD EBOOK

"The goal is to provide a comprehensive reference book for the preclinicaldiscovery and development scientist whose responsibilities span target identification,
Nonclinical Safety Assessment
Language: en
Pages: 492
Authors: William J. Brock
Categories: Medical
Type: BOOK - Published: 2013-03-05 - Publisher: John Wiley & Sons

DOWNLOAD EBOOK

Nonclinical Safety Assessment Nonclinical Safety Assessment A Guide to International Pharmaceutical Regulations Bringing a new drug to market is a costly time-c